Clinical development of natural killer cells expressing chimeric antigen receptors
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 60 (1) , 103065
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing ProtocolFrontiers in Oncology, 2013
- Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene TherapyHuman Gene Therapy, 2012
- Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular MechanismsJournal of Virology, 2011
- Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in Human and Other Primate Cell LinesJournal of Biomedicine and Biotechnology, 2010
- Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral methodCancer Gene Therapy, 2009
- 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma CellsClinical Cancer Research, 2009
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell TherapyCancer Research, 2009
- T Cell ActivationAnnual Review of Immunology, 2009
- Cytokine-induced memory-like natural killer cellsProceedings of the National Academy of Sciences, 2009
- Evolutionary struggles between NK cells and virusesNature Reviews Immunology, 2008